We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Stada Arzneimittel confirmed Thursday that it has "postponed" planned presentations to bidding groups, which reportedly include two competing private equity consortia that have made offers worth about 3.7 billion euros ($4 billion).